Fig. 4.
CD85j (ILT2) expression on CD56-depleted Lin−HLA-DR+ PBMCs.
(A) CD11c labeling demonstrates heterogeneous CD85j expression within both the CD11c+ and CD11c− compartments. (B) The CD123hi subset is CD85j+, indicating that the CD34+ subset lacks CD85j expression.